Disclosure: This guide is published by LevelsRx, which is one of the platforms reviewed below and is listed first. We have a direct financial interest in that platform. This is not an independent third-party evaluation, and our assessments are editorial opinions rather than the results of clinical testing or measured patient outcomes.
For informational purposes only — not medical advice. GLP-1 and other weight-management medications require a prescription from a licensed healthcare provider, and eligibility is determined case by case following a clinical evaluation. A consultation does not guarantee a prescription. Consult a qualified healthcare provider before starting or changing any weight-loss medication.
In This Guide
- Executive Summary
- Methodology: how we evaluated these platforms
- The 10 leading providers reviewed
- What these medications do — and their risks
- Determining your ideal match
- Final assessment
- Common questions about GLP-1 telehealth
- Industry updates
- Supplemental resources
- Explore specialized care
Our editorial team reviewed the leading platforms on clinical structure, medication sourcing, and patient support. Descriptions below reflect what each company states publicly on its own website as of August 2026.
We have not verified pricing figures, and we have deliberately omitted them — subscription rates, what they include, and commitment terms change frequently, and an out-of-date price is worse than none. Confirm current costs directly with each provider, and ask specifically whether the quoted price includes the medication, lab work, and provider visits.
Executive Summary
- LevelsRx (our platform): ongoing metabolic monitoring and lab data alongside obesity medicine care.
- WeightWatchers Clinic: integration of prescribing with an established behavioral nutrition framework.
- Ro: dedicated insurance verification and prior authorization support.
- Mochi Health: multidisciplinary model with registered dietitian involvement.
- Hims & Hers: cash-pay access, primarily compounded formulations.
- Calibrate, PlushCare, Found, Sesame, and Noom Med round out the list, each covered in detail below.
Methodology: how we evaluated these platforms
We assessed each platform against five operational pillars, using publicly available information from each company as of August 2026.
We did not measure patient outcomes, and no assessment on this page is a claim that one platform produces better weight-loss results than another.
- Pricing architecture. Whether costs are clearly defined and whether provider fees are separated from medication expenses. We describe structure only; we do not publish figures.
- Pharmaceutical sourcing. Whether the clinic prescribes FDA-approved brand-name products, works with 503A or 503B compounding facilities, or offers both.
- Administrative support. How the provider handles prior authorizations and commercial insurance appeals. No platform can guarantee an approval outcome.
- Provider credentials. The clinician qualifications each platform states publicly. These are the platforms’ own representations; individual credentials can be verified through state medical boards.
- Longitudinal care. Follow-up frequency and the extent of ongoing monitoring.
The 10 leading providers reviewed
1. LevelsRx — data-informed metabolic care
Brand-name and compounded options · Insurance navigation support · Ongoing lab and biometric monitoring
LevelsRx (disclosure: our own platform) pairs ongoing metabolic monitoring with obesity medicine care. Rather than a prescription-only model, clinicians review lab results and biometric data alongside what you report about how you are feeling, and use both to inform dosing decisions over the course of treatment.
Patients work with the same clinical team across visits, so changes to a protocol are made in the context of your history rather than at a single intake appointment. Our team also files prior authorizations and manages appeals with commercial insurers, though no platform can guarantee that an insurer will approve coverage.
What we are not claiming: we do not publish an average weight loss figure for our patients, and we make no claim that this model produces more weight loss or fewer side effects than another platform. We do not have controlled data that would support such a comparison. Weight-loss outcomes depend on the specific medication, your medical history, diet, physical activity, and adherence to treatment, and they vary considerably between individuals.
Ideal candidates: individuals who want ongoing clinical oversight and monitoring rather than a single prescribing visit.
2. WeightWatchers Clinic — behavioral framework plus medication
Brand-name focus · App integration · Behavioral tracking ecosystem
Building on its acquisition of Sequence, this service combines GLP-1 prescribing with WeightWatchers’ behavioral tracking program. The app provides daily structure for meal planning and physical activity, with a nutrition emphasis that includes protein intake and physical activity — both of which clinical guidance identifies as important during rapid weight loss, though no program can guarantee preservation of lean muscle mass.
The clinical team states that it handles prior authorizations on patients’ behalf.
Ideal candidates: people who benefit from community support and structured behavioral eating plans alongside medical treatment.
3. Ro — insurance navigation and a polished patient experience
Brand-name and compounded options · Insurance verification support · Video and asynchronous visits
Ro offers a streamlined patient experience through its Body Program. Its most distinctive operational feature is a dedicated team focused on insurance verification and prior authorization, which the company positions as a way to reduce the administrative burden on patients.
Ro offers both commercially available brand-name medications and compounded formulations. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality; a compounded formulation is not a generic version of, and is not equivalent to, Ozempic, Wegovy, Mounjaro, or Zepbound.
Ideal candidates: people who want a low-friction experience and hands-on help navigating commercial insurance requirements.
4. Hims & Hers — cash-pay access with compounded formulations
Compounded focus · Cash-pay · Asynchronous intake
This platform operates largely in the cash-pay compounded medication market, with detailed clinical intake forms and assessment by licensed providers. Bundled pricing is part of its positioning; confirm exactly what a given plan includes before enrolling.
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. In September 2025 the FDA issued warning letters to telehealth companies, including Hims & Hers, over marketing language describing compounded semaglutide as containing the same active ingredient as Ozempic and Wegovy in ways the agency found implied equivalence to the approved products. Ask any platform directly which pharmacy fills your prescription and whether it is a 503A pharmacy or a 503B outsourcing facility.
Ideal candidates: uninsured or underinsured patients considering compounded options who understand the regulatory difference from FDA-approved products.
5. Mochi Health — multidisciplinary care with dietitian involvement
Brand-name and compounded options · Registered dietitian access · Video consultations
Mochi Health emphasizes multidisciplinary care, with check-ins with registered dietitians alongside prescribing clinicians. The stated goal of the dual-provider model is to help patients build habits that persist beyond pharmaceutical treatment.
The platform states that it accommodates complex medical histories and that its clinicians include board-certified obesity medicine specialists. Individual clinician credentials can be verified through your state medical board.
Ideal candidates: patients who want structured nutritional coaching built into their medical care.
6. Calibrate — structured one-year metabolic program
Brand-name only · Commercial insurance focus · Biweekly coaching
Calibrate operates a year-long program built around behavioral coaching and metabolic lab testing. It prescribes FDA-approved brand-name formulations only and does not prescribe compounded medications.
Patients meet regularly with coaches focused on sleep, diet, exercise, and habit change. Confirm the current commitment length and cancellation terms directly with the company before enrolling — programs with annual terms may carry early-termination conditions.
Ideal candidates: people with commercial insurance coverage who want a structured, longer-term behavioral program.
7. PlushCare — primary care model with insurance billing
Brand-name only · Accepts major insurance for visits · Scheduled video appointments
PlushCare functions as a primary care service rather than a standalone weight clinic. You book a specific appointment time, meet by video, and the visit can be billed to your existing insurance much like an in-person appointment.
It does not offer compounded medications, focusing instead on clinical evaluation and documentation to support insurance coverage for brand-name treatments.
Ideal candidates: patients who want a conventional doctor-patient relationship and to manage general primary care alongside weight management.
8. Found — broader range of oral options
Oral and injectable options · Includes medications prescribed off-label
Found offers a wider range of oral prescription medications alongside injectables. Some oral weight-management medications are FDA-approved for that use, and some are prescribed off-label — off-label prescribing is legal and common, but it means the medication was not FDA-approved for weight management specifically. Ask your provider which category anything you are prescribed falls into.
Ideal candidates: patients exploring non-injectable options, or those for whom injectables are not appropriate.
Editorial note before publishing: verify Found’s current medication offerings and program structure against its own website and record the date checked.
9. Sesame — direct-pay marketplace
Brand-name focus · Cash marketplace · Per-visit booking
Sesame operates as a direct-to-consumer marketplace where patients book individual independent practitioners. There is no ongoing subscription requirement, and patients pay per consultation.
Because clinicians are independent, continuity of care and ongoing monitoring are not automatically built in, and a consultation does not guarantee a prescription — a clinician may reasonably determine that medication is not appropriate for you.
Ideal candidates: patients who prefer paying per visit rather than committing to a recurring membership.
10. Noom Med — behavioral psychology plus clinical support
Brand-name focus · Insurance navigation · Behavior-tracking integration
Noom Med adds clinical support to Noom’s behavior-change application, with the aim of addressing eating behavior and appetite regulation together rather than separately.
Clinicians reference data logged in the app when discussing dosing and progress. As with any program, a licensed provider makes the final clinical determination.
Ideal candidates: existing Noom users who want to add clinical care to a behavioral program they already use.
What these medications do — and their risks
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) act on hormone pathways involved in appetite regulation and gastric emptying, which is why many patients report reduced hunger. In the manufacturers’ pivotal trials, patients taking these medications alongside a reduced-calorie diet and increased physical activity lost significantly more weight than those on placebo. Those results belong to the drugs as studied under trial conditions. They are not a prediction of any individual’s outcome, and they are not results produced by any telehealth platform, including ours.
As with all medications, GLP-1 drugs can cause side effects. Common ones include nausea, vomiting, diarrhea, constipation, and abdominal pain, particularly when starting treatment or increasing a dose. Less common but serious risks described in FDA prescribing information include pancreatitis, gallbladder disease, kidney injury from dehydration, and diabetic retinopathy complications in some patients. Semaglutide and tirzepatide carry an FDA boxed warning regarding thyroid C-cell tumors observed in rodent studies and are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Discuss your full medical history — including thyroid conditions, pancreatitis, gallbladder disease, gastrointestinal disorders, and any history of disordered eating — with a licensed provider before starting.
Determining your ideal match
Matching your clinical needs to a provider’s operational strengths matters more than any ranking. Insurance status, medical history, and how much ongoing contact you want should drive the decision — ideally in conversation with a clinician who knows your history.
If you want ongoing biological monitoring and clinical oversight throughout treatment, LevelsRx (our platform) is built around that model. If your priority is working within a specific commercial insurance formulary, Ro and PlushCare both emphasize administrative support for coverage. If you want behavioral structure, Calibrate, WeightWatchers Clinic, and Noom Med each approach it differently.
Final assessment
The telehealth weight management sector in 2026 has divided into distinct sub-specialties, with general primary care models giving way to dedicated metabolic care teams. Review your financial situation and clinical requirements carefully before committing to a program with an annual term, and confirm that your provider uses clinicians licensed in your state.
The single most important question to ask any platform: is what you are prescribing an FDA-approved product or a compounded formulation, and which pharmacy fills it? Get the answer in writing.
Common questions about GLP-1 telehealth
Which platform offers the most comprehensive metabolic care in 2026?
That depends on what you need, and any answer we give is an answer from an interested party — LevelsRx publishes this guide. Our platform emphasizes ongoing lab monitoring and biometric data alongside prescribing rather than a single intake visit, which suits patients who want continuous oversight. Platforms with a stronger behavioral curriculum or a specialist-only clinician network may suit others better. We are not claiming our model produces better clinical results, because we do not have comparative data that would support that claim.
Are compounded medications safe to buy online?
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. The 503A and 503B distinction matters: 503B outsourcing facilities register with the FDA and are subject to current good manufacturing practice requirements and inspection, while 503A pharmacies are regulated primarily by state boards of pharmacy. Neither status means the FDA has reviewed the specific product you receive. A compounded formulation is not a generic version of, and is not equivalent to, an FDA-approved medication. If you are considering one, ask which facility type prepares it, ask for a certificate of analysis, and discuss the trade-offs with your prescribing clinician.
Can I use employer insurance for these services?
Telehealth membership fees are often cash-pay, while the medication itself may be covered depending on your plan. Several platforms, including WeightWatchers Clinic and PlushCare, state that they assist with obtaining coverage for the medication. Many plans exclude weight-management medications entirely, and no platform can guarantee approval.
Is a live video consultation required to get a prescription?
Requirements vary by state. Some platforms use secure asynchronous messaging and detailed clinical questionnaires where state law permits. In every case a licensed clinician must evaluate you and determine whether treatment is appropriate; asynchronous intake changes the format of that evaluation, not the requirement for it.
Industry updates
Note: the items below describe developments reported by third parties. Add a citation and date to each before publishing, and remove any item you cannot source to a primary document such as a company announcement, FDA communication, or published trial registration.
Manufacturing capacity. Manufacturers have reported expanded production capacity for injectable metabolic treatments. Supply availability continues to vary by product, dose, and region — check current FDA drug shortage listings rather than relying on any platform’s characterization.
Investigational compounds in development. Several next-generation agonist compounds are in clinical trials. These are investigational products. They are not FDA-approved, are not available by prescription, and their safety and efficacy have not been established. We are not characterizing trial results here; refer to the published trial data and registration records.
Insurance formulary changes. Some commercial carriers have revised coverage criteria for weight-management medications. Criteria differ substantially between carriers and plans — confirm your own plan’s current requirements with your insurer.
Supplemental resources
- Understanding ongoing biometric monitoring in metabolic care
- Compounded versus FDA-approved medications: what the regulatory difference means
- How prior authorization works with commercial carriers
- Working with a registered dietitian during GLP-1 treatment
- Managing gastrointestinal side effects during dose escalation
Explore specialized care
Browse treatment pathways by clinical need: metabolic monitoring · maintenance protocols · behavioral therapy integration · dietitian-led programs · medication sourcing options.
Service areas: Austin · Seattle · Atlanta · Boston · San Diego · Nashville · Portland · Charlotte · Las Vegas · Orlando · Columbus
Availability depends on clinician licensure in your state. Confirm coverage for your location before enrolling.
| Last reviewed August 2026 by Sacha. We review this page quarterly. This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before starting any weight-loss medication. LevelsRx publishes this guide and is featured in it. If any outbound link on this page is compensated, disclose that here. |
